In this episode of Concentrating on Chromatography, David speaks with Francis Femi Oloy about using chromatography to uncover hidden pollutants in real-world water systems.Femi’s team analyzed polychlorinated biphenyls (PCBs) in six major rivers in southwestern Nigeria — compounds that were banned decades ago but still persist in the environment. Using a workflow that many analytical labs will recognize — liquid–liquid extraction, cleanup, rotary evaporation, nitrogen blowdown, and GC-ECD detection — they quantified 25 PCB congeners at trace levels and linked the results to ecological and human health risk.📌 In this conversation, we cover:• Why legacy pollutants like PCBs still show up today• Choosing GC-ECD vs LC-MS for halogenated compounds• Liquid–liquid extraction and matrix cleanup strategies• Why sample concentration is critical for dilute environmental samples• How rotovap + nitrogen blowdown work together without losing volatile analytes• Seasonal trends (why wet season levels were higher)• Translating concentration data into meaningful risk assessmentsThis episode is perfect for anyone working in:Chromatography • Environmental analysis • Sample prep • Trace analysis • GC methods • Analytical chemistryIf you enjoy practical discussions about real laboratory workflows and how chromatography solves real problems, subscribe to Concentrating on Chromatography. 🔬 Paper discussed: Polychlorinated biphenyls (PCBs) in rivers of Southwestern Nigeria: sources, seasonal distribution, and assessment of human health risks# 🔔 More episodesSubscribe for more interviews with scientists using chromatography and mass spectrometry to solve real-world challenges.

How do you see proteins, metals, and disease processes inside real tissue — and still trust the numbers?In this episode of Concentrating on Chromatography, David sits down with Monique Mello, analytical chemist, educator, and LA-ICP-MS imaging specialist, to explore how laser ablation ICP-MS (LA-ICP-MS) and immuno-mass spectrometry imaging (iMSI) are transforming pathology, environmental science, and translational research.Monique shares her journey from public-health and pathology labs in Brazil to environmental and biomedical research in Australia — and explains why metrology, traceability, and defensible measurements are the foundation of meaningful science.We dive into her work developing multiplexed elemental imaging methods that allow researchers to quantify multiple proteins at once in tissue — revealing interactions that traditional single-marker methods miss. Her studies show how LA-ICP-MS can map dystrophin-glycoprotein complex proteins in muscular dystrophy and track elemental distributions like zinc in Alzheimer’s disease tissue.We also discuss something many labs overlook: sample preparation and immunolabelling can change the chemistry you’re trying to measure. Monique’s research demonstrates how staining steps can redistribute endogenous metals and why rigorous validation is critical for trustworthy data.If you care about chromatography, mass spectrometry, or analytical chemistry that genuinely impacts patients and communities, this episode is for you.In this conversation, we cover:• What LA-ICP-MS imaging is and how it works• Multiplexed antibody tagging with lanthanides for quantitative tissue imaging• Why metrology and uncertainty matter more than “pretty data”• Common analytical failures (and why sample prep causes most of them)• Elemental mapping in muscular dystrophy and Alzheimer’s research• How immunolabelling and coverslipping can perturb endogenous metals• Teaching analytical chemistry for real-world problem solvingWho this is for: Analytical chemists • Mass spectrometrists • Chromatographers • Pathology researchers • Environmental scientists • Students entering the field

How do chemists design molecules that safely carry radioactive metals through the body to target cancer cells?

In this episode of Concentrating on Chromatography, David sits down with Simona Mastroianni and Marianna Tosato to explore the chemistry behind radiopharmaceuticals — drugs that combine radioactive isotopes with specially designed chelators to diagnose and treat cancer.

Their latest research focuses on the theranostic pair lead-203 and lead-212, a powerful combination that enables both imaging and targeted alpha therapy using the same chemical platform. To make this possible, they developed new “molecular cages” that tightly bind lead ions, improving stability, safety, and effectiveness in the body.

Along the way, we break down:

• What radiopharmaceuticals and theranostics actually mean

• Why chelators act like cages for radioactive metals

• How chromatography (HPLC/TLC) verifies radiolabeling and purity

• How NMR shows metals are truly bound

• The path from synthetic chemistry → animal studies → hospitals

• Career advice for undergraduate chemists interested in medical and radiochemistry

If you’ve ever wondered how analytical chemistry, inorganic chemistry, and separation science translate into real cancer treatments, this episode connects the dots.Based on their recent publication demonstrating highly stable, efficiently labeled cyclen-based chelators for 203/212Pb radiopharmaceuticals and the full interview discussion .🎧

Perfect for students in:Analytical chemistry • Chromatography • Inorganic chemistry • Radiochemistry • Pharmaceutical sciences

radiopharmaceuticals, lead-212 therapy, theranostics, chelators, chromatography, HPLC, NMR, radiochemistry, cancer drug development, analytical chemistry careers